"Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014 ...
[USPRwire, Tue Dec 23 2014] GlobalData's clinical trial report, "Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014" provides data on the Gram-Positive Bacterial Infections clinical trial scenario. This report provides elemental ...
USPRwire (press release) - Mon, 29 Dec 2014 19:22

Novel polymer coating reduced catheter's bacteria spread
Researchers from the University of Edinburgh fabricated polymer microarrays by contact printing of preformed polymers and cultured a variety of gram-negative and gram-positive bacteria on the arrays to identify potentially repellent polymers. The most ...
Healio - Fri, 23 Jan 2015 10:33



Tricking Soil Bacteria to Grow in Lab: Discovering a Class of Antibiotics to ...
According to study results, Teixobactin can target only gram-positive bacteria, because gram-negative bacteria have an extra outer wall for protection. ... “If we are infected with these bacteria, we can't be treated with the antibiotics they're ...
Daily Nexus - Fri, 23 Jan 2015 16:11

CHMP Says Yes to Two Antibiotics for Skin Infections
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of two antibiotics for the treatment of adults with acute bacterial skin and skin structure infections (ABSSSI): oritavancin (Orbactiv ...
Medscape - Fri, 23 Jan 2015 11:30



Teixobactin appears to avoid bacteria resistance [PreClinical]
1. The newly discovered antibacterial compound teixobactin, isolated from the soil bacteria Eleftheria terrae, targeted cell wall synthesis in gram-positive bacteria without leading to resistant mutants. 2. In three mouse models of bacterial infection ...
2 Minute Medicine - Tue, 20 Jan 2015 20:52

Grant Hill-Cawthorne says it will take two decades for bacteria to develop ...
The Australian - Tue, 20 Jan 2015 05:05

Promising Antibiotic Discovered in Dirt
The Bottom Line - Tue, 20 Jan 2015 23:09

Finding a new antibiotic
The Manitoban - Mon, 19 Jan 2015 15:48

Huntsville company begins clinical tests on bacteria detection product
iCubate will seek clearance from the Food & Drug Administration as an in-vitro diagnostic test to be used for the identification and detection of "gram-positive" bacteria, which are the most common cause of bacterial bloodstream infections. Gram ...
WAFF - Wed, 14 Jan 2015 14:18

Huntsville biotech company iCubate begins clinical study of new bloodstream ...
AL.com - Wed, 14 Jan 2015 14:07



iCubate product to test deadly bacteria detection
Gram-positive bacteria, such as Staphylococcus, are the most bacterial contaminants of blood, and the company will use an in-vitro diagnostic test to try to find it. This bacteria is the most common cause of bacterial bloodstream infections, and the ...
WAAY - Mon, 19 Jan 2015 11:41

Antibiotics: An irresistible newcomer
Furthermore, infectious-disease practitioners and public-health leaders advise against extensive use of new antibiotics, with the aim of slowing the development of resistance, and this results in reduced sales of any new product. In recognition of ...
Nature.com - Wed, 21 Jan 2015 10:10


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014